APA (7th ed.) Citation

Amer, H., Griffin, M. D., Stegall, M. D., Cosio, F. G., Park, W. D., Kremers, W. K., . . . Kumar, R. (2013). Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial. American journal of transplantation, 13(6), 1576-1585. https://doi.org/10.1111/ajt.12227

Chicago Style (17th ed.) Citation

Amer, H., et al. "Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial." American Journal of Transplantation 13, no. 6 (2013): 1576-1585. https://doi.org/10.1111/ajt.12227.

MLA (9th ed.) Citation

Amer, H., et al. "Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial." American Journal of Transplantation, vol. 13, no. 6, 2013, pp. 1576-1585, https://doi.org/10.1111/ajt.12227.